Global Business Reports (GBR)’s Post

'Viruses Are Back: Humanity and the USA Life Sciences Industry' Climate change and human activities are expanding the range of tropical diseases into new areas, creating a need for innovative solutions in vaccine development and virus prevention. Some investors are now focusing on climate tech alongside traditional biotech investments, recognizing the interconnected nature of human health and environmental issues. Read the article here: https://lnkd.in/eSbNMmWX Interbiome Partners Aphios Corporation Prince Sterilization Services Planetary Health Alliance #USALifeSciences #Article #PharmaceuticalIndustry #US #GBR

Viruses Are Back: Humanity, and the Life Sciences Industry - United States Life Sciences 2024

Viruses Are Back: Humanity, and the Life Sciences Industry - United States Life Sciences 2024

projects.gbreports.com

Laura Magaña

President & CEO of the Association of Schools and Programs of Public Health (ASPPH); President of the Global Network for Academic Public Health (GNAPH)

2w

This topic is incredibly important! Thank you for highlighting this crucial intersection of climate change and human health. The expansion of tropical diseases due to changing climates emphasizes the urgent need for innovation in virus prevention and vaccine development.

Like
Reply

To view or add a comment, sign in

Explore topics